MSB 3.83% $1.26 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-308

  1. 7,794 Posts.
    lightbulb Created with Sketch. 1341
    So this is a phase 1 study.

    I should hope everyone here has already read these, these studies were the foundation for the current trials that were just run.

    You can find most of them on the MSB website, where it is in a much easier to read format. I'd suggest you read them if you haven't, they're interesting and really should be a part of anyone's DD if you're investing.

    And these studies alone don't prove the therapy works. That's what phase 3 helps with
    Last edited by DocMcstuffins: 21/02/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $21.32M 17.21M

Buyers (Bids)

No. Vol. Price($)
4 5460 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 978 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.